PLUS THERAPEUTICS Files 8-K
Ticker: PSTV · Form: 8-K · Filed: 2026-04-08T07:30:07-04:00
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
PLUS THERAPEUTICS filed an 8-K, likely routine updates. Check exhibits for details.
AI Summary
On April 8, 2026, PLUS THERAPEUTICS, INC. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates that PLUS THERAPEUTICS, INC. has submitted a standard regulatory report to the SEC, which may contain updates or disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events or financial distress.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Filer of the 8-K report
- 0001095981 (company) — CIK number for PLUS THERAPEUTICS, INC.
- 2026-04-08 (date) — Period of Report and Filing Date
FAQ
What specific events are detailed under Item 8.01 of the filing?
The provided excerpt states Item 8.01 pertains to 'Other Events,' but does not specify what those events are.
What financial statements or exhibits are included in the filing?
The filing includes Item 9.01, covering 'Financial Statements and Exhibits,' with specific documents like an 8-K in iXBRL format and an exhibit EX-99.1 listed.
What is the mailing address of PLUS THERAPEUTICS, INC.?
The mailing address is 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756.
What is the CIK number for PLUS THERAPEUTICS, INC.?
The CIK number for PLUS THERAPEUTICS, INC. is 0001095981.
What is the primary business classification for PLUS THERAPEUTICS, INC. according to the SIC code?
The SIC code 3841 indicates the company is in 'Surgical & Medical Instruments & Apparatus'.
From the Filing
EDGAR Filing Documents for 0001193125-26-146335 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-146335 Filing Date 2026-04-08 Accepted 2026-04-08 07:30:07 Documents 10 Period of Report 2026-04-08 Items Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K pstv-20260408.htm iXBRL 8-K 49927 2 EX-99.1 pstv-ex99_1.htm EX-99.1 24737 Complete submission text file 0001193125-26-146335.txt 196440 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20260408.xsd EX-101.SCH 31920 13 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20260408_htm.xml XML 4716 Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194 PLUS THERAPEUTICS, INC. (Filer) CIK : 0001095981 (see all company filings) EIN. : 330827593 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 26846518 SIC : 3841 Surgical & Medical Instruments & Apparatus (CF Office: 08 Industrial Applications and Services)